EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exogenous adenosine counteracts tigecycline resistance in tet (X3)-harboring Escherichia coli

Jing Sun, Yiming Liu, Jiashen Chang, Ying Liu, Luqi Li, Ran Jiang, Yihan Luo, Shuo Yang, Mei Yang, Xinglong Wang iD, Juan Wang, Xi Xia iD und 3 weitere

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.02382-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Jing Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China. Hauptthemen laut MEDLINE: Tigecycline, Escherichia coli, Anti-Bacterial Agents, Adenosine. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid spread of antibiotic resistance poses a global health crisis. Tigecycline is a last-resort antibiotic, but the recent emergence of the plasmid-borne tet (X3) gene conferring high-level tigecycline resistance is deeply concerning. Here, we report a metabolomics-guided approach to overcome tet (X3)-mediated resistance. Using untargeted metabolomics, we identified adenosine as a key metabolic biomarker associated with tet (X3) expression. Remarkably, supplementation with exogenous adenosine was able to restore tigecycline susceptibility in tet (X3)-positive Escherichia coli both in vitro and in vivo . Our mechanistic investigations reveal that adenosine enhances the bactericidal effects of tigecycline by inducing oxidative stress, DNA/RNA damage, and cell membrane disruption in resistant bacteria. This study establishes a powerful metabolomics-driven strategy to potentiate antibiotic efficacy against drug-resistant pathogens. The adenosine-based adjuvant therapy represents a promising approach to combat the global crisis of antibiotic resistance. IMPORTANCE The emergence and widespread dissemination of the high-level tigecycline resistance gene tet (X3) have posed a significant challenge to the efficacy of tigecycline, which serves as the “last line of defense” against antimicrobial-resistant bacteria. Although tigecycline has not been approved for veterinary clinical use, constant detection of tet (X3) genes and new subtypes in livestock farming environments poses a substantial threat to public health safety. While developing novel antibiotics is an effective approach to eradicate resistance genes/bacteria, it entails considerable costs and a lengthy timeframe. This study discovered that exogenous adenosine can effectively restore the sensitivity of tet (X3)-positive Escherichia coli to tigecycline through metabolic reprogramming based on a non-targeted metabolomics strategy. The findings are highly significant for exploring comprehensive mechanisms underlying bacterial multidrug resistance, utilizing metabolic reprogramming strategies to curb the spread of novel resistant genes, and treating clinical infections caused by tet (X3)-positive bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TigecyclineEscherichia coliAnti-Bacterial AgentsAdenosineDrug Resistance, BacterialMicrobial Sensitivity TestsAnimalsEscherichia coli InfectionsMetabolomicsEscherichia coli Proteins

Stichwörter der Autor:innen

adenosineantimicrobial resistancemetabolomicstet(X3)tigecycline

Substanzen

TigecyclineAnti-Bacterial AgentsAdenosineEscherichia coli Proteins

Autor:innen und Institutionen

  • College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China.
  • Experimental Animal Center, Northwest A&F University, Yangling, Shaanxi, China.
  • Life Science Research Core Services, Northwest A&F University, Yangling, Shaanxi, China.
  • Key Laboratory of Ruminant Disease Prevention and Control (West), Ministry of Agriculture and Rural Affairs, Yangling, Shaanxi, China.
  • Key Laboratory of Animal-Derived Bacterial Resistance Monitoring (Co-Construction), Ministry of Agriculture and Rural Affairs, Yangling, Shaanxi, China.
  • National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China.

ORCID-Profile: Xinglong Wang, Xi Xia, Dongyang Ye

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Sun, J., Liu, Y., Chang, J., Liu, Y., Li, L., Jiang, R., Luo, Y., Yang, S., Yang, M., Wang, X., Wang, J., Xia, X., Guo, K., Yang, Z., & Ye, D. (2025). Exogenous adenosine counteracts tigecycline resistance in tet (X3)-harboring Escherichia coli. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02382-24

Vancouver

Sun J, Liu Y, Chang J, Liu Y, Li L, Jiang R, et al. Exogenous adenosine counteracts tigecycline resistance in tet (X3)-harboring Escherichia coli. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02382-24

BibTeX
@article{Sun2025,
  author = {Sun, Jing and Liu, Yiming and Chang, Jiashen and Liu, Ying and Li, Luqi and Jiang, Ran and Luo, Yihan and Yang, Shuo and Yang, Mei and Wang, Xinglong and Wang, Juan and Xia, Xi and Guo, Kangkang and Yang, Zengqi and Ye, Dongyang},
  title = {Exogenous adenosine counteracts tigecycline resistance in tet (X3)-harboring Escherichia coli},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.02382-24}
}
Kostenlos starten →